SHRO Italia, in collaboration with Unicamillus and Hiera Care & Research Institute, organized a II level Master’s degree with the aim of training professionals with advanced and innovative knowledge in the pharmacological and biotechnological fields.
The educational objectives of the courses concern the different aspects of regenerative medicine, students will be provided with knowledge regarding stem cells, endogenous and experimental regeneration, tissue engineering and the use of innovative biomaterials, sampling methods, expansion, culture, manipulation cellular, monitoring, storage and traceability, and understanding the regulatory needs of such emerging technologies.
The topic of technological transfer of biotechnology in public and private institutions will also be addressed as the student will be able to aspire to hold positions in local health companies, hospitals, IRCCS, polyclinics, private health companies, research and training centers operating in the regenerative medicine sector . The employment impact will also be guaranteed by the constantly evolving needs of qualified personnel of the entities participating in the Master’s program such as companies, hospitals and cell factories.
By focusing attention on the clinical field, the master’s degree course ensures students have an in-depth knowledge of the current diagnostic processes aimed at identifying the type of pathological lesions and the subsequent anatomical-physiopathological and functional characterization.
Estimated start date of the Master: 6 December 2024
Venue of the Master: Polo Tecnologico Piemontese
- lessons at the UniCamillus University – Rome and at the Polo Tecnologico Piemontese -Candiolo
- Mandatory internships and practical exercises will be carried out at the headquarters of the Sbarro Health Research Organization (SHRO) Foundation in Italy, affiliated private structures and the Institute of Science, Technology and Sustainability for the Development of Ceramic Materials of the CNR-ISSMC.
English language
Duration: 12 months
Final certification of qualifications and training credits:
Those who have completed the required training course and passed the final evaluation test will be awarded the title of Second Level University Master in ‘BLOOD COMPONENTS, CELLS AND BIOMATERIALS FOR TRANSLATIONAL REGENERATIVE MEDICINE AND TISSUE ENGINEERING’ with the attribution of 60 training credits (CFU).
To find out more: https://www.unicamillus.org/it/master-emocomponenti-cellule-e-biomateriali-per-la-medicina-rigenerativa-traslazionale-e-lenergia-dei-tessuti/